ACUPAN

This brand name is authorized in Nigeria. It is also authorized in France, New Zealand, Romania, Tunisia, UK.

Active ingredients

The drug ACUPAN contains one active pharmaceutical ingredient (API):

1	Nefopam UNII 685J48E13W - NEFOPAM HYDROCHLORIDE
	Read more about Nefopam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5504	Injection	ACUPAN INJECTION INJ 20 mg 2ML X 5AMP	20 RNW-PP-263783 ACUPAN INJECTION NEFOPAM HCL 20MG NEFOPAM HCL 20MG A4-5504 Drugs Imported Products 2MLx5AMP Prescription Only Medicine (POM) 6/15/2022 MERIT HEALTHCARE LIMITED, DELE ASHIRU STREET, IRE-AKARI ESTATE ISOLO LAGOS 8171273639 casmolar1@yahoo.com Biocodex, 1, avenue Blaise Pascal 60 000 Beauvais France., France	31/10/2023

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACUPAN Tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BG06	Nefopam	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BG Other analgesics and antipyretics
Discover more medicines within N02BG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	62580656
NG	Registered Drug Product Database	A4-5504
NZ	Medicines and Medical Devices Safety Authority	2482
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43861001, W43861002
TN	Direction de la Pharmacie et du Médicament	5193031